Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design

by Constantin N. Baxevanis, Sotirios P. Fortis, Alexandros Ardavanis, Sonia A. Perez
Published 2020-10-01

HLA Class I Allele Expression and Clinical Outcome in De Novo Metastatic Prostate Cancer

by Savvas Stokidis, Sotirios P. Fortis, Paraskevi Kogionou, Theodoros Anagnostou, Sonia A. Perez, Constantin N. Baxevanis
Published 2020-06-01

Gradient 3D Printed PLA Scaffolds on Biomedical Titanium: Mechanical Evaluation and Biocompatibility

by Diana V. Portan, Christos Ntoulias, Georgios Mantzouranis, Athanassios P. Fortis, Despina D. Deligianni, Demosthenes Polyzos, Vassilis Kostopoulos
Published 2021-02-01

In Situ Characterization of Follicular Helper CD4 T Cells Using Multiplexed Imaging

by Kalliopi Ioannidou, Daba-Rokhya Ndiaye, Alessandra Noto, Craig Fenwick, Sotirios P. Fortis, Giuseppe Pantaleo, Constantinos Petrovas, Constantinos Petrovas, Laurence de Leval
Published 2021-02-01

Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

by Sotirios P. Fortis, Michael Sofopoulos, Nectaria N. Sotiriadou, Christoforos Haritos, Christoforos K. Vaxevanis, Eleftheria A. Anastasopoulou, Nicole Janssen, Niki Arnogiannaki, Alexandros Ardavanis, Graham Pawelec, Sonia A. Perez, Constantin N. Baxevanis
Published 2017-04-01

Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

by Sotirios P. Fortis, Michael Sofopoulos, Nectaria N. Sotiriadou, Christoforos Haritos, Christoforos K. Vaxevanis, Eleftheria A. Anastasopoulou, Nicole Janssen, Niki Arnogiannaki, Alexandros Ardavanis, Graham Pawelec, Sonia A. Perez, Constantin N. Baxevanis
Published 2017-05-01

Coagulation Abnormalities in Renal Pathology of Chronic Kidney Disease: The Interplay between Blood Cells and Soluble Factors

by Efthimia G. Pavlou, Hara T. Georgatzakou, Sotirios P. Fortis, Konstantina A. Tsante, Andreas G. Tsantes, Efrosyni G. Nomikou, Athanasia I. Kapota, Dimitrios I. Petras, Maria S. Venetikou, Effie G. Papageorgiou, Marianna H. Antonelou, Anastasios G. Kriebardis
Published 2021-09-01

Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes in lymph nodes and reduces SHIV RNA

by G. Pavlakis, D.C. Watson, E. Moysi, A. Valentin, C. Bergamaschi, S. Devasundaram, S.P. Fortis, J. Bear, E. Chertova, J. Bess, Jr., R. Sowder, D.J. Venzon, C. Deleage, J.D. Estes, J.D. Lifson, C. Petrovas, B.K. Felber
Published 2017-12-01

Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes.

by Dionysios C Watson, Eirini Moysi, Antonio Valentin, Cristina Bergamaschi, Santhi Devasundaram, Sotirios P Fortis, Jenifer Bear, Elena Chertova, Julian Bess, Ray Sowder, David J Venzon, Claire Deleage, Jacob D Estes, Jeffrey D Lifson, Constantinos Petrovas, Barbara K Felber, George N Pavlakis
Published 2018-02-01

Correction: Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes.

by Dionysios C Watson, Eirini Moysi, Antonio Valentin, Cristina Bergamaschi, Santhi Devasundaram, Sotirios P Fortis, Jenifer Bear, Elena Chertova, Julian Bess, Ray Sowder, David J Venzon, Claire Deleage, Jacob D Estes, Jeffrey D Lifson, Constantinos Petrovas, Barbara K Felber, George N Pavlakis
Published 2018-10-01